HeartWare to float new shares
Thursday, 05 June, 2008
HeartWare (ASX: HTW) will hold an extraordinary general meeting next month to receive shareholder permission to float up to 70 million new shares.
The shares will be offered privately to professional investors in Australia and the US, and will be sold at $0.50 cents a share.
The purpose of the listing is to raise $30 million in capital. HeartWare, which manufactures miniature medical devices, will offer a share purchase plan to allow current stockholders the opportunity to purchase the new shares at the same price as that offered to the private investors.
Organoid platform enables closer study of bat-borne viruses
Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...
Global study finds 250 genes linked to OCD
Researchers say they have found the genes linked to obsessive compulsive disorder (OCD), after...
TGA approves therapy for paediatric growth hormone deficiency
The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged...
